EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic, Germany, Italy and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Juel Kjeldsen, Lene
Linked to EAHP Statements
Section 1 – Introductory Statements and Governance: Statement 1.1, 1.3, 1.4, 1.5, 1.6, 1.7
ACPE UAN: 0475-0000-21-009-L04-P. A knowledge-based activity.
Abstract
Opportunities in healthcare are changing rapidly with developments of new technologies, use of AI, telemedicine, 3D printing and access to innovative drugs and treatments. This calls for hospital re-design using, for instance, robotics and digital technologies in the routine treatment of patients. At the same time, there has been an increased focus on personalised medical treatment using genomics analysis, nano-technology (devices inside the body), treatment of patients in their own homes etc. These opportunities will most likely lead to better treatment of patients.
Concurrently, the users of healthcare are changing. Patient empowerment is a new focus, and patients express higher demands to the healthcare system and healthcare providers, including hospital pharmacists. This may result in increased competition within healthcare and create new demands on healthcare professionals in the way we view, communicate and treat patients. However, healthcare professionals also experience new opportunities during their training using e.g. virtual reality and simulations to empower them to better meet patient needs.
The downside of all the new possible treatment opportunities is cost. New technologies and drugs are often very expensive. The proportion of elderly people is growing throughout Europe, which will lead to increased pressure on healthcare systems since elderly people have more diagnoses and treatment needs. This calls for prioritisation in healthcare and the risk of polarisation in access to healthcare services.
Learning objectives
After the session, participants should be able to:
• recall important areas of innovation within hospital care;
• list elements of interest to hospital pharmacists to be addressed in preparation to solve future tasks;
• recognise new tasks and educational needs of hospital pharmacists to be able to provide the best possible care of hospitalised patients in the future.
Educational need addressed
It is essential for hospital pharmacists to look into the future possibilities and needs within hospital care. In order to be prepared and able to deliver the best possible treatment of hospitalised patients.
Keywords: new technology, innovative drugs, hospital design, AI, pharmaceutical care.
